safety or efficacy concerns regarding our product candidates may result from any concerns arising from nonclinical or clinical testing of other therapies targeting a similar disease state or other therapies, such as gene therapy, that are perceived as similar to oursAnd the point you were arguing that the German head of Bayer said wasn't saying the RNA vaccines were gene therapy, because someone with English as their second language said "for" instead of "of", was wrong. He further clarified that if people knew that mRNA vaccines were gene therapy most wouldn't accept the vaccine.
In their own written words both Pfizer and Moderna admit their mRNA products are gene therapy, and considered to be so by the FDA.
Do we have disagreement on what gene therapy is?
As you've pointed out above, they also make clear there has been no approval for mRNA medicines before and they accurately predict their preclinical and clinical trials may be approved on different criteria that has been established for gene therapy products, which means many requirements like reproductive toxicity, ADE studies were not completed.
Both Pfizer and Moderna's own documents make it clear "No mRNA drug has been approved in this new potential class of medicines, and may never be approved as a result of efforts by others or us. mRNA drug development has substantial clinical development and regulatory risks due to the novel and unprecedented nature of this new class of medicines."
Regulatory requirements governing gene and cell therapy products have evolved and may continue to change in the future, and the implications for mRNA-based therapies are unknown.
Even if we obtain regulatory approval for an investigational medicine, including mRNA-1273 (Moderna), our products will remain subject to regulatory scrutiny. For example, the holder of an approved BLA is obligated to monitor and report adverse events and any failure of a product to meet the specifications in the BLA.
It's pretty clear that you and I disagree on whether these vaccines are gene therapy. I don't see that changing so is there any point continuing?
Last edited:





